Human Alternative Macrophages Populate Calcified Areas of Atherosclerotic Lesions and Display Impaired RANKL-Induced Osteoclastic Bone Resorption Activity
Overview
Authors
Affiliations
Rationale: Vascular calcification is a process similar to bone formation leading to an inappropriate deposition of calcium phosphate minerals in advanced atherosclerotic plaques. Monocyte-derived macrophages, located in atherosclerotic lesions and presenting heterogeneous phenotypes, from classical proinflammatory M1 to alternative anti-inflammatory M2 macrophages, could potentially display osteoclast-like functions.
Objective: To characterize the phenotype of macrophages located in areas surrounding the calcium deposits in human atherosclerotic plaques.
Methods And Results: Macrophages near calcium deposits display an alternative phenotype being both CD68 and mannose receptor-positive, expressing carbonic anhydrase type II, but relatively low levels of cathepsin K. In vitro interleukin-4-polarization of human primary monocytes into macrophages results in lower expression and activity of cathepsin K compared with resting unpolarized macrophages. Moreover, interleukin-4 polarization lowers expression levels of the osteoclast transcriptional activator nuclear factor of activated T cells type c-1, associated with increased gene promoter levels of the transcriptional repression mark H3K27me3 (histone 3 lysine 27 trimethylation). Despite higher expression of the receptor activator of nuclear factor κB receptor, receptor activator of nuclear factor κB ligand/macrophage colony-stimulating factor induction of nuclear factor of activated T cells type c-1 and cathepsin K expression is defective in these macrophages because of reduced Erk/c-fos-mediated downstream signaling resulting in impaired bone resorption capacity.
Conclusions: These results indicate that macrophages surrounding calcium deposits in human atherosclerotic plaques are phenotypically defective being unable to resorb calcification.
Macrophages in Calcific Aortic Valve Disease: Paracrine and Juxtacrine Disease Drivers.
Klauzen P, Basovich L, Shishkova D, Markova V, Malashicheva A Biomolecules. 2025; 14(12.
PMID: 39766254 PMC: 11673549. DOI: 10.3390/biom14121547.
Zhu S, Liu Y, Bu W, Liu Y, Chen W, Liu F Heliyon. 2024; 10(19):e37957.
PMID: 39386883 PMC: 11462233. DOI: 10.1016/j.heliyon.2024.e37957.
Beyond the Basics: Unraveling the Complexity of Coronary Artery Calcification.
Hashmi S, Shah P, Aherrahrou Z, Aikawa E, Aherrahrou R Cells. 2023; 12(24).
PMID: 38132141 PMC: 10742130. DOI: 10.3390/cells12242822.
Namous H, Strillacci M, Braz C, Shanmuganayagam D, Krueger C, Peppas A Atheroscler Plus. 2023; 54:30-41.
PMID: 38116576 PMC: 10728570. DOI: 10.1016/j.athplu.2023.11.001.
Moratal C, Murdaca J, Cruzel C, Zamiti-Smondel A, Heme N, Asarisi F Int J Cardiol Heart Vasc. 2023; 49:101309.
PMID: 38020056 PMC: 10679475. DOI: 10.1016/j.ijcha.2023.101309.